Report of the First ONTOX Stakeholder Network Meeting : Digging Under the Surface of ONTOX Together With the Stakeholders
The first Stakeholder Network Meeting of the EU Horizon 2020-funded ONTOX project was held on 13-14 March 2023, in Brussels, Belgium. The discussion centred around identifying specific challenges, barriers and drivers in relation to the implementation of non-animal new approach methodologies (NAMs) and probabilistic risk assessment (PRA), in order to help address the issues and rank them according to their associated level of difficulty. ONTOX aims to advance the assessment of chemical risk to humans, without the use of animal testing, by developing non-animal NAMs and PRA in line with 21st century toxicity testing principles. Stakeholder groups (regulatory authorities, companies, academia, non-governmental organisations) were identified and invited to participate in a meeting and a survey, by which their current position in relation to the implementation of NAMs and PRA was ascertained, as well as specific challenges and drivers highlighted. The survey analysis revealed areas of agreement and disagreement among stakeholders on topics such as capacity building, sustainability, regulatory acceptance, validation of adverse outcome pathways, acceptance of artificial intelligence (AI) in risk assessment, and guaranteeing consumer safety. The stakeholder network meeting resulted in the identification of barriers, drivers and specific challenges that need to be addressed. Breakout groups discussed topics such as hazard versus risk assessment, future reliance on AI and machine learning, regulatory requirements for industry and sustainability of the ONTOX Hub platform. The outputs from these discussions provided insights for overcoming barriers and leveraging drivers for implementing NAMs and PRA. It was concluded that there is a continued need for stakeholder engagement, including the organisation of a 'hackathon' to tackle challenges, to ensure the successful implementation of NAMs and PRA in chemical risk assessment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
Alternatives to laboratory animals : ATLA - 52(2024), 2 vom: 01. März, Seite 117-131 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.03.2024 Date Revised 14.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/02611929231225730 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367262355 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367262355 | ||
| 003 | DE-627 | ||
| 005 | 20240314234915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240118s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/02611929231225730 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1329.xml |
| 035 | |a (DE-627)NLM367262355 | ||
| 035 | |a (NLM)38235727 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Diemar, Michael G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Report of the First ONTOX Stakeholder Network Meeting |b Digging Under the Surface of ONTOX Together With the Stakeholders |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2024 | ||
| 500 | |a Date Revised 14.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The first Stakeholder Network Meeting of the EU Horizon 2020-funded ONTOX project was held on 13-14 March 2023, in Brussels, Belgium. The discussion centred around identifying specific challenges, barriers and drivers in relation to the implementation of non-animal new approach methodologies (NAMs) and probabilistic risk assessment (PRA), in order to help address the issues and rank them according to their associated level of difficulty. ONTOX aims to advance the assessment of chemical risk to humans, without the use of animal testing, by developing non-animal NAMs and PRA in line with 21st century toxicity testing principles. Stakeholder groups (regulatory authorities, companies, academia, non-governmental organisations) were identified and invited to participate in a meeting and a survey, by which their current position in relation to the implementation of NAMs and PRA was ascertained, as well as specific challenges and drivers highlighted. The survey analysis revealed areas of agreement and disagreement among stakeholders on topics such as capacity building, sustainability, regulatory acceptance, validation of adverse outcome pathways, acceptance of artificial intelligence (AI) in risk assessment, and guaranteeing consumer safety. The stakeholder network meeting resulted in the identification of barriers, drivers and specific challenges that need to be addressed. Breakout groups discussed topics such as hazard versus risk assessment, future reliance on AI and machine learning, regulatory requirements for industry and sustainability of the ONTOX Hub platform. The outputs from these discussions provided insights for overcoming barriers and leveraging drivers for implementing NAMs and PRA. It was concluded that there is a continued need for stakeholder engagement, including the organisation of a 'hackathon' to tackle challenges, to ensure the successful implementation of NAMs and PRA in chemical risk assessment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a NAMs | |
| 650 | 4 | |a artificial intelligence | |
| 650 | 4 | |a confidence | |
| 650 | 4 | |a end-user acceptance | |
| 650 | 4 | |a hackathon | |
| 650 | 4 | |a new approach methodologies | |
| 650 | 4 | |a next generation risk assessment | |
| 650 | 4 | |a non-animal | |
| 650 | 4 | |a probabilistic risk assessment | |
| 650 | 4 | |a stakeholder network | |
| 650 | 4 | |a toxicology | |
| 700 | 1 | |a Vinken, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Teunis, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Krul, Cyrille A M |e verfasserin |4 aut | |
| 700 | 1 | |a Busquet, Francois |e verfasserin |4 aut | |
| 700 | 1 | |a Zajac, Julia Dominika |e verfasserin |4 aut | |
| 700 | 1 | |a Kandarova, Helena |e verfasserin |4 aut | |
| 700 | 1 | |a Corvi, Raffaella |e verfasserin |4 aut | |
| 700 | 1 | |a Rosso, Matteo Z |e verfasserin |4 aut | |
| 700 | 1 | |a Kharina, Anastasiia |e verfasserin |4 aut | |
| 700 | 1 | |a Bryndum, Louise Stab |e verfasserin |4 aut | |
| 700 | 1 | |a Santillo, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Bloch, Denise |e verfasserin |4 aut | |
| 700 | 1 | |a Kucheryavenko, Olena |e verfasserin |4 aut | |
| 700 | 1 | |a Panagiotakos, Demosthenes |e verfasserin |4 aut | |
| 700 | 1 | |a Rogiers, Vera |e verfasserin |4 aut | |
| 700 | 1 | |a Beekhuijzen, Manon |e verfasserin |4 aut | |
| 700 | 1 | |a Giusti, Arianna |e verfasserin |4 aut | |
| 700 | 1 | |a Najjar, Abdulkarim |e verfasserin |4 aut | |
| 700 | 1 | |a Courage, Carol |e verfasserin |4 aut | |
| 700 | 1 | |a Koenig, Torben |e verfasserin |4 aut | |
| 700 | 1 | |a Kolle, Susanne |e verfasserin |4 aut | |
| 700 | 1 | |a Boonen, Harrie |e verfasserin |4 aut | |
| 700 | 1 | |a Dhalluin, Stephane |e verfasserin |4 aut | |
| 700 | 1 | |a Boberg, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Boris P |e verfasserin |4 aut | |
| 700 | 1 | |a Kukic, Predrag |e verfasserin |4 aut | |
| 700 | 1 | |a Ritskes-Hoitinga, Merel |e verfasserin |4 aut | |
| 700 | 1 | |a Grasselli, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Zietek, Tamara |e verfasserin |4 aut | |
| 700 | 1 | |a Stoddart, Gilly |e verfasserin |4 aut | |
| 700 | 1 | |a Heusinkveld, Harm J |e verfasserin |4 aut | |
| 700 | 1 | |a Castell, Jose V |e verfasserin |4 aut | |
| 700 | 1 | |a Benfenati, Emilio |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Huan |e verfasserin |4 aut | |
| 700 | 1 | |a Perera, Simón |e verfasserin |4 aut | |
| 700 | 1 | |a Paini, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Kramer, Nynke I |e verfasserin |4 aut | |
| 700 | 1 | |a Hartung, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Janssen, Manoe |e verfasserin |4 aut | |
| 700 | 1 | |a Fritsche, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Jennen, Danyel G J |e verfasserin |4 aut | |
| 700 | 1 | |a Piumatti, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Rathman, James |e verfasserin |4 aut | |
| 700 | 1 | |a Marusczyk, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Milec, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Roggen, Erwin L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alternatives to laboratory animals : ATLA |d 1985 |g 52(2024), 2 vom: 01. März, Seite 117-131 |w (DE-627)NLM080851657 |x 0261-1929 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2024 |g number:2 |g day:01 |g month:03 |g pages:117-131 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/02611929231225730 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2024 |e 2 |b 01 |c 03 |h 117-131 | ||